See more : Olema Pharmaceuticals, Inc. (OLMA) Income Statement Analysis – Financial Results
Complete financial analysis of Innovest Global, Inc. (IVST) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Innovest Global, Inc., a leading company in the Conglomerates industry within the Industrials sector.
- Sipai Health Technology Co., Ltd. (0314.HK) Income Statement Analysis – Financial Results
- The Musashino Bank, Ltd. (8336.T) Income Statement Analysis – Financial Results
- Grifco International, Inc. (GFCI) Income Statement Analysis – Financial Results
- Alpha Healthcare Acquisition Corp. (AHACU) Income Statement Analysis – Financial Results
- SDI Corporation (2351.TW) Income Statement Analysis – Financial Results
Innovest Global, Inc. (IVST)
About Innovest Global, Inc.
Innovest Global, Inc. engages in the commercial and industrial, energy, and biotechnology and health services sectors. It designs, engineers, tests, and manufactures curtain wall systems; supplies personal protection equipment, apparel, and safety supplies; offers inbound and outbound call services; negotiates and purchases various exterior building products. The company also provides energy services to reduce businesses overall energy costs; and LED lighting products, as well as acts as independent energy broker. In addition, it develops immunotherapeutic for treating patients with glioblastoma multiforme. The company was formerly known as Aurum Resource and Asset Management, Inc. and changed its name to Innovest Global, Inc. in January 2017. Innovest Global, Inc. was incorporated in 1999 and is based in Chesterland, Ohio.
Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 0.00 | 0.00 | 7.53M | 40.24M | 6.55M | 49.76K | 0.00 | 0.00 | 0.00 | 1.72M | 1.13M | 822.85K | 842.81K | 771.58K |
Cost of Revenue | 0.00 | 0.00 | 4.97M | 49.27M | 4.83M | 26.12K | 0.00 | 0.00 | 0.00 | 875.87K | 555.18K | 446.55K | 407.66K | 437.05K |
Gross Profit | 0.00 | 0.00 | 2.56M | -9.04M | 1.71M | 23.63K | 0.00 | 0.00 | 0.00 | 846.09K | 578.43K | 376.30K | 435.15K | 334.53K |
Gross Profit Ratio | 0.00% | 0.00% | 33.99% | -22.47% | 26.17% | 47.50% | 0.00% | 0.00% | 0.00% | 49.14% | 51.03% | 45.73% | 51.63% | 43.36% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.26M | 380.81K | 280.60K | 250.14K | 245.54K |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 210.05K | 172.99K | 160.11K | 165.20K | 172.38K |
SG&A | 0.00 | 0.00 | 6.53M | 7.43M | 4.27M | 147.98K | 85.38K | 1.75K | 12.56K | 2.47M | 553.80K | 440.71K | 415.35K | 417.92K |
Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 400.00 | 2.60K | 2.94K | 3.44K | 0.00 |
Operating Expenses | 0.00 | 0.00 | 6.53M | 7.43M | 4.27M | 147.98K | 85.38K | 1.75K | 12.56K | 2.47M | 556.40K | 443.64K | 418.78K | 423.05K |
Cost & Expenses | 0.00 | 0.00 | 11.50M | 56.70M | 9.10M | 174.10K | 85.38K | 1.75K | 12.56K | 3.34M | 1.11M | 890.20K | 826.44K | 860.11K |
Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 24.06 | 4.15 | 0.00 | 0.00 | 0.00 | 9.18K | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 0.00 | 0.00 | 274.21K | 29.15K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 4.95K | 2.32K | 2.26K | 0.00 | 4.00 |
Depreciation & Amortization | 228.49K | 236.56K | 471.05K | 526.43K | 24.46K | 120.19 | 0.00 | 0.00 | 0.00 | 400.00 | 2.60K | 2.94K | 3.44K | 5.13K |
EBITDA | 0.00 | 0.00 | -3.72M | -18.94M | -2.53M | -124.28K | -85.38K | -1.75K | -12.56K | -1.61M | 15.18K | -64.41K | 19.81K | -83.39K |
EBITDA Ratio | 0.00% | 0.00% | -46.55% | -39.62% | -38.68% | -249.90% | 0.00% | 0.00% | 0.00% | -94.11% | 1.34% | -7.83% | 2.35% | -8.97% |
Operating Income | 0.00 | 0.00 | -3.97M | -16.47M | -2.56M | -124.34K | -85.38K | -1.75K | -12.56K | -1.62M | 12.58K | -67.34K | 16.37K | -88.52K |
Operating Income Ratio | 0.00% | 0.00% | -52.81% | -40.93% | -39.06% | -249.90% | 0.00% | 0.00% | 0.00% | -94.14% | 1.11% | -8.18% | 1.94% | -11.47% |
Total Other Income/Expenses | 0.00 | 0.00 | -488.01K | -3.03M | -2.34M | 55.00 | -3.00 | 0.00 | -31.92K | -19.00K | 9.46K | -2.26K | 0.00 | -14.19K |
Income Before Tax | 0.00 | 0.00 | -4.46M | -19.49M | -4.90M | -124.29K | -85.38K | -1.75K | 0.00 | 0.00 | 22.03K | 0.00 | 0.00 | -102.72K |
Income Before Tax Ratio | 0.00% | 0.00% | -59.29% | -48.45% | -74.85% | -249.79% | 0.00% | 0.00% | 0.00% | 0.00% | 1.94% | 0.00% | 0.00% | -13.31% |
Income Tax Expense | 0.00 | 0.00 | -1.00 | -2.00 | 2.00 | -120.19 | 0.00 | 0.00 | -135.18K | -4.23K | -7.14K | 2.26K | 0.00 | 14.20K |
Net Income | 0.00 | 0.00 | -4.46M | -19.49M | -4.90M | -124.29K | -85.38K | -1.75K | 122.62K | -1.62M | 29.18K | -69.61K | 16.37K | -102.72K |
Net Income Ratio | 0.00% | 0.00% | -59.29% | -48.45% | -74.85% | -249.79% | 0.00% | 0.00% | 0.00% | -93.89% | 2.57% | -8.46% | 1.94% | -13.31% |
EPS | 0.00 | 0.00 | -0.02 | -0.13 | -0.03 | 0.00 | 0.00 | 0.00 | 130.45 | -1.72K | 0.00 | -74.05 | 17.41 | -109.28 |
EPS Diluted | 0.00 | 0.00 | -0.02 | -0.13 | -0.03 | 0.00 | 0.00 | 0.00 | 130.45 | -1.72K | 0.00 | -74.05 | 17.41 | -109.28 |
Weighted Avg Shares Out | 0.00 | 0.00 | 183.74M | 149.10M | 141.05M | 62.34M | 62.34M | 62.34M | 940.00 | 940.00 | 0.00 | 940.00 | 940.00 | 940.00 |
Weighted Avg Shares Out (Dil) | 0.00 | 0.00 | 183.74M | 149.10M | 141.05M | 62.34M | 62.34M | 62.34M | 940.00 | 940.00 | 0.00 | 940.00 | 940.00 | 940.00 |
Innovest Global Signs Letter of Intent to Acquire Natural Gas Supplier
Source: https://incomestatements.info
Category: Stock Reports